SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-197029
Filing Date
2024-08-08
Accepted
2024-08-08 16:42:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d881350ds3.htm S-3 399167
2 EX-4.5 d881350dex45.htm EX-4.5 396237
3 EX-5.1 d881350dex51.htm EX-5.1 17545
4 EX-5.2 d881350dex52.htm EX-5.2 8768
5 EX-23.1 d881350dex231.htm EX-23.1 1943
6 EX-FILING FEES d881350dexfilingfees.htm EX-FILING FEES 77582
7 GRAPHIC g881350g02s03.jpg GRAPHIC 41010
8 GRAPHIC g881350g0806083127859.jpg GRAPHIC 3306
9 GRAPHIC g881350g36a36.jpg GRAPHIC 68909
  Complete submission text file 0001193125-24-197029.txt   1058777
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281391 | Film No.: 241189170
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)